[Immunological development in asymptomatic HIV infected children]

Area of Science:

• Pediatric Immunology
• Virology
• Immunology

Context:

• Human thymus involution necessitates early antiretroviral therapy (ART) for vertically HIV-infected children.
• CD4+ T-lymphocyte reconstitution is linked to thymopoiesis in HIV-infected children.
• Understanding immune reconstitution in asymptomatic, untreated children is crucial for therapeutic strategies.

Purpose:

• To investigate T-cell subset reconstitution in vertically HIV-infected children naive for therapy versus those on nucleoside analogues.
• To compare immunological development in HIV-infected children with significant viremia but no HAART (highly active antiretroviral therapy).
• To assess if asymptomatic HIV-1 infected children can achieve normal immunological development in the first decade.

Summary:

• This study followed 12 vertically HIV-infected children (aged 4-8) for four years, comparing 7 therapy-naive children (group NT) with 5 on nucleoside analogues (group T).
• No significant differences in viral load, CD4+ T-lymphocytes, or CD45RA+/CD45RO+ T-cell subsets were observed between groups or over time.
• Median CD45RA+ values were comparable to healthy children, indicating normal immune development despite viremia in therapy-naive children.

Impact:

• Suggests that normal immunological development is possible in asymptomatic, vertically HIV-infected children during the first decade, even without HAART.
• Highlights the potential for effective T-cell reconstitution and thymopoiesis in specific pediatric HIV populations.
• Informs clinical recommendations regarding the timing and necessity of early HAART initiation in asymptomatic, vertically HIV-infected children.